The presence of tumor thrombus extending into the inferior vena cava (IVC) is a rare complication of
hepatocellular carcinoma (HCC), presenting in only 3.8% of patients, resulting in a median survival of 1.9
months. Even rarer and likely with worse outcomes is a tumor extending from the IVC into the right atrium
and ventricle. Here we present the case of a 55-year-old male with advanced liver cirrhosis from nonalcoholic steatohepatitis (NASH) with a diagnosis of HCC and IVC tumor thrombus invading into the right
atrium and ventricle. The patient was treated with stereotactic body radiotherapy (SBRT) to 30Gy in 5
fractions delivered over 5 days targeting the right atrium, right ventricle and the outflow tract. Initially, the
patient had a radiographic and clinical response to treatment, with minimal acute toxicities. Unfortunately,
due to declining liver function, the patient subsequently entered hospice care and died 4 months posttreatment. This case demonstrates the poor prognosis of this advanced presentation of disease but suggests
that SBRT is a safe and reasonable treatment approach for the reduction of IVC and cardiac tumor thrombus
in HCC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.